193 related articles for article (PubMed ID: 11730316)
21. [Proton pump inhibitors and H2-receptor antagonists: their effect on the urea breath test in Helicobacter pylori diagnosis].
Riepl RL; Otto B
Z Gastroenterol; 1999 Nov; 37(11):1129-32. PubMed ID: 10604229
[No Abstract] [Full Text] [Related]
22. Helicobacter pylori eradication in peptic dyspepsia.
Lule GN
East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
[No Abstract] [Full Text] [Related]
23. Functional dyspepsia: where do we stand?
Lamers CB
Scand J Gastroenterol Suppl; 1993; 200():96-7. PubMed ID: 7912448
[TBL] [Abstract][Full Text] [Related]
24. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
25. [Meta-analysis should be regarded with extreme caution].
Miehlke S; Malfertheimer P
Z Gastroenterol; 1996 Aug; 34(8):XVIII-XX; author reply XX-XXII. PubMed ID: 8967119
[No Abstract] [Full Text] [Related]
26. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
27. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
Scarpignato C
Dig Liver Dis; 2005 Jul; 37(7):468-74. PubMed ID: 15893968
[No Abstract] [Full Text] [Related]
28. Clinical inquiries. Is therapy based on endoscopy results better than empiric therapy for dyspepsia?
Rich K; Safranek S; Malaty W
J Fam Pract; 2005 Aug; 54(8):725-6. PubMed ID: 16061065
[No Abstract] [Full Text] [Related]
29. [Meta-analysis raises more questions, than it answers].
Petersen KU
Z Gastroenterol; 1996 Aug; 34(8):XVII; author reply XX-XXII. PubMed ID: 8967117
[No Abstract] [Full Text] [Related]
30. [Meta-analyses are hardly suitable for conclusively proving medical controversies].
Stolte M
Z Gastroenterol; 1996 Aug; 34(8):XVII-XVIII; author reply XX-XXII. PubMed ID: 8967118
[No Abstract] [Full Text] [Related]
31. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
[TBL] [Abstract][Full Text] [Related]
32. Smoking increases the treatment failure for Helicobacter pylori eradication.
Suzuki T; Matsuo K; Ito H; Sawaki A; Hirose K; Wakai K; Sato S; Nakamura T; Yamao K; Ueda R; Tajima K
Am J Med; 2006 Mar; 119(3):217-24. PubMed ID: 16490464
[TBL] [Abstract][Full Text] [Related]
33. Guidelines for the management of dyspepsia.
Talley NJ; Vakil N;
Am J Gastroenterol; 2005 Oct; 100(10):2324-37. PubMed ID: 16181387
[TBL] [Abstract][Full Text] [Related]
34. Impact of Helicobacter pylori on the management of dyspepsia in primary care.
Bennett K; Feely J; Thornton O; Dobson M; O'Morain CA; O'Connor HJ
Aliment Pharmacol Ther; 2006 Aug; 24(4):637-41. PubMed ID: 16907896
[TBL] [Abstract][Full Text] [Related]
35. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
[TBL] [Abstract][Full Text] [Related]
36. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Chassany O; Bergmann JF
Rev Prat; 1998 Apr; 48(8):893-8. PubMed ID: 11767336
[No Abstract] [Full Text] [Related]
37. [GERD/reflux esophagitis].
Hongo M; Tamura D
Nihon Rinsho; 2002 Feb; 60 Suppl 2():608-13. PubMed ID: 11979856
[No Abstract] [Full Text] [Related]
38. [Stress ulcer].
Kato K; Arakawa Y
Nihon Rinsho; 2002 Feb; 60 Suppl 2():619-24. PubMed ID: 11979858
[No Abstract] [Full Text] [Related]
39. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
40. Update on the role of drug therapy in non-ulcer dyspepsia.
Talley NJ
Rev Gastroenterol Disord; 2003; 3(1):25-30. PubMed ID: 12684590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
